Athersys, Angiotech Gain On Stem Cell Study
Athersys, Angiotech Gain On Stem Cell Study
[Read the full article here]Related News:
Athersys completes enrollment in phase I MultiStem allogeneic stem cell therapy clinical trial
Stem cell company Athersys gets grant to study traumatic brain injury
Athersys Gets U.S. Patent Covering Adult Stem Cell Composition …

